newcleo plc reports Q3 results
newcleo plc reported Q3 2026 revenue of $10B, up 26% YoY. Capital expenditures decreased to €11.3M from €12.9M. Cash reserves grew to €233.4M from €90.4M.
newcleo plc
newcleo develops lead-cooled fast reactors and mixed oxide nuclear fuel made from reprocessed materials. The company conducts nuclear energy research and development, supports fuel-cycle closure, and provides engineering, procurement, and construction services. Its activities include operating a pilot MOX fuel manufacturing line and developing projects for energy independence. newcleo serves nuclear operators and organizations involved in reactor design, fuel production, and energy supply initiatives. It is based in London, United Kingdom.
No SEC Form 4 filings for $NWCL in the last 30 days.
See all $NWCL insider activity →newcleo plc reported Q3 2026 revenue of $10B, up 26% YoY. Capital expenditures decreased to €11.3M from €12.9M. Cash reserves grew to €233.4M from €90.4M.
newcleo (NASDAQ:NWCL) partnered with Curio to supply recycled nuclear fuel for its U.S. MOX fuel facility. The deal secures fuel materials for newcleo's reactors and advances recycling tech. newcleo is engaging with the U.S. Nuclear Regulatory Commission for a license.
newcleo plc (Nasdaq: NWCL) acquired Bonifait Pesage, a French nuclear-grade scale maker, to support its US and European MOX fuel manufacturing. The deal aligns with newcleo's vertical integration strategy, securing supply and reducing exposure. Bonifait Pesage's revenue is approximately $50M. The acquisition aims to enhance tracking and control of nuclear materials.
Over the past 7 days, AlphAI's AI scored 4 news stories mentioning NWCL (newcleo plc). Coverage has skewed bullish: 3 bullish, 1 neutral, and 0 bearish.
Recent NWCL coverage spans earnings, technology and financial news.
The disclosed Q3 revenue growth and improved cash position are likely supportive, but the article provides no guidance or profitability detail to confirm earnings power.
The agreement de‑risks Newcleo's fuel supply chain, potentially supporting its growth outlook.
Acquisition reduces supply‑chain risk and may improve margins for Newcleo's upcoming fuel facilities.
Neutral rating may limit upside and could sustain recent downside pressure.
The new center should accelerate fuel development and may improve investor sentiment.
AlphAI scores every news story that mentions NWCL with an AI model for sentiment and relevance, and aggregates insider trades from newcleo plc's SEC EDGAR Form 4 filings. Figures refresh continuously.
newcleo plc reported Q3 2026 revenue of $10B, up 26% YoY. Capital expenditures decreased to €11.3M from €12.9M. Cash reserves grew to €233.4M from €90.4M.
newcleo (NASDAQ:NWCL) partnered with Curio to supply recycled nuclear fuel for its U.S. MOX fuel facility. The deal secures fuel materials for newcleo's reactors and advances recycling tech. newcleo is engaging with the U.S. Nuclear Regulatory Commission for a license.
newcleo plc (Nasdaq: NWCL) acquired Bonifait Pesage, a French nuclear-grade scale maker, to support its US and European MOX fuel manufacturing. The deal aligns with newcleo's vertical integration strategy, securing supply and reducing exposure. Bonifait Pesage's revenue is approximately $50M. The acquisition aims to enhance tracking and control of nuclear materials.
BTIG initiated coverage on Newcleo (NASDAQ:NWCL) with a Neutral rating, citing its development timeline. The stock, trading near its 52-week low, has declined over 20% in the past week. Newcleo is developing nuclear technology, with plans to bring its first MOX plant online in 2031 and its first lead-cooled reactor in 2032. BTIG notes the company's financial flexibility but remains unprofitable with a loss of $0.34 per share over the last twelve months.
newcleo plc (NASDAQ: NWCL) inaugurated FASTER, a nuclear fuel engineering and testing center in France. The facility tests key stages of MOX fuel manufacturing, aiming to optimize processes before industrial deployment. The company plans to use the center to support its fuel manufacturing facilities in France and the U.S.
newcleo plc reported its first half 2026 results, including $247M from a SPAC merger and $18.7M in additional financing. Revenue rose 46% to €19.4M, but net loss increased 10% to €82M. The company installed a key component for its PRECURSOR reactor and advanced regulatory plans for its lead-cooled fast reactor and MOX fuel facility. It also announced acquisitions and partnerships, including a deal with Oklo for the U.S. Department of Energy's plutonium program.
newcleo plc, a nuclear technology company, began trading on the Nasdaq Global Select Market on September 22, 2026, under the ticker symbols NWCL and NWCLW. The company plans to use the capital to accelerate its reactor and fuel manufacturing technology deployment in Europe and the U.S. newcleo aims to deliver clean, safe, and sustainable energy at competitive costs.
Medical Microinstruments (MMI) raised 17M euros from Angelini Ventures and EIB. Newcleo, a nuclear energy startup, may list on Nasdaq after a 2.4B USD pre-money valuation. Tundr Tech secured 11.6M euros in Series A funding. Investors include CDP Venture Capital, 360 Capital, and others.